Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1954 2
1957 2
1959 1
1960 1
1961 1
1964 2
1965 3
1966 4
1969 2
1971 3
1972 4
1973 5
1974 1
1975 2
1976 3
1977 1
1978 4
1979 4
1980 2
1981 4
1982 1
1983 1
1984 4
1985 5
1986 4
1987 9
1988 6
1989 8
1990 10
1991 8
1992 6
1993 6
1994 10
1995 7
1996 7
1997 6
1998 6
1999 10
2000 3
2001 6
2002 4
2003 10
2004 13
2005 15
2006 14
2007 12
2008 18
2009 16
2010 18
2011 30
2012 37
2013 36
2014 35
2015 50
2016 47
2017 41
2018 63
2019 49
2020 62
2021 62
2022 63
2023 46
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

841 results

Results by year

Filters applied: . Clear all
Page 1
High frequency trauma: The new worl order?
Fajardo-Campoverdi A, Ibarra-Estrada M, González-Castro A, Cortés A, Núñez-Silveira J. Fajardo-Campoverdi A, et al. Among authors: cortes a. Med Intensiva (Engl Ed). 2024 Apr 8:S2173-5727(24)00063-8. doi: 10.1016/j.medine.2024.03.010. Online ahead of print. Med Intensiva (Engl Ed). 2024. PMID: 38594111 No abstract available.
RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity.
Singh S, Fang J, Jin H, Van de Velde LA, Wu Q, Cortes A, Morton CL, Woolard MA, Quarni W, Steele JA, Connelly JP, He L, Thorne R, Turner G, Confer T, Johnson M, Caufield WV, Freeman BB, Lockey T, Pruett-Miller SM, Wang R, Davidoff AM, Thomas PG, Yang J. Singh S, et al. Among authors: cortes a. bioRxiv [Preprint]. 2024 Mar 25:2024.03.21.586157. doi: 10.1101/2024.03.21.586157. bioRxiv. 2024. PMID: 38585889 Free PMC article. Preprint.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Pérez-García JM, Cortés J, Ruiz-Borrego M, Colleoni M, Stradella A, Bermejo B, Dalenc F, Escrivá-de-Romaní S, Calvo Martínez L, Ribelles N, Marmé F, Cortés A, Albacar C, Gebhart G, Prat A, Kerrou K, Schmid P, Braga S, Di Cosimo S, Gion M, Antonarelli G, Popa C, Szostak E, Alcalá-López D, Gener P, Rodríguez-Morató J, Mina L, Sampayo-Cordero M, Llombart-Cussac A; PHERGain Trial Investigators. Pérez-García JM, et al. Among authors: cortes a. Lancet. 2024 Apr 27;403(10437):1649-1659. doi: 10.1016/S0140-6736(24)00054-0. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582092 Clinical Trial.
Adoptive T cell therapy for solid tumors: current landscape and future challenges.
Albarrán V, San Román M, Pozas J, Chamorro J, Rosero DI, Guerrero P, Calvo JC, González C, García de Quevedo C, Pérez de Aguado P, Moreno J, Cortés A, Soria A. Albarrán V, et al. Among authors: cortes a. Front Immunol. 2024 Mar 14;15:1352805. doi: 10.3389/fimmu.2024.1352805. eCollection 2024. Front Immunol. 2024. PMID: 38550594 Free PMC article. Review.
Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates.
Cartas-Cejudo P, Cortés A, Lachén-Montes M, Anaya-Cubero E, Puerta E, Solas M, Fernández-Irigoyen J, Santamaría E. Cartas-Cejudo P, et al. Among authors: cortes a. Brain Pathol. 2024 Mar 7:e13252. doi: 10.1111/bpa.13252. Online ahead of print. Brain Pathol. 2024. PMID: 38454090
841 results